Fusarium Keratitis in Taiwan: Molecular Identification, Antifungal Susceptibilities, and Clinical Features

We performed molecular identification and antifungal susceptibilities of pathogens and investigated clinical features of 43 culture-proven Fusarium keratitis cases from 2015–2020 in Taiwan. The pathogens were identified by sequencing of their internal transcribed spacer regions of ribosomal DNA and translation elongation factor 1α gene; their antifungal susceptibilities (to seven agents) were determined by broth microdilution method. We also collected clinical data to compare the drug susceptibilities and clinical features of Fusarium solani species complex (FSSC) isolates with those of other Fusarium species complexes (non-FSSC). The FSSC accounted for 76.7% pathogens, among which F. falciforme (32.6%) and F. keratoplasticum (27.9%) were the most common species. Among clinically used antifungal agents, amphotericin B registered the lowest minimal inhibitory concentration (MIC), and the new azoles efinaconazole, lanoconazole and luliconazole, demonstrated even lower MICs against Fusarium species. The MICs of natamycin, voriconazole, chlorhexidine, lanoconazole, and luliconazole were higher for the FSSC than the non-FSSC, but no significant differences were noted in clinical outcomes, including corneal perforation and final visual acuity. In Taiwan, the FSSC was the most common complex in Fusarium keratitis; its MICs for five tested antifungal agents were higher than those of non-FSSC, but the clinical outcomes did not differ significantly.

[1]  Savitri Sharma,et al.  Distribution, prevalence, and causative agents of fungal keratitis: A systematic review and meta-analysis (1990 to 2020) , 2021, bioRxiv.

[2]  Hung-Chi Chen,et al.  Filamentous Fungal Keratitis in Taiwan: Based on Molecular Diagnosis , 2020, Translational vision science & technology.

[3]  J. V. van Rooij,et al.  Epidemiology and Clinical Management of Fusarium keratitis in the Netherlands, 2005–2016 , 2020, Frontiers in Cellular and Infection Microbiology.

[4]  K. Makimura,et al.  In vitro antifungal activity of luliconazole against nondermatophytic moulds. , 2019, Medical mycology.

[5]  M. Burton,et al.  In Vitro Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Fusarium Isolates Recovered from Fungal Keratitis Patients , 2019, Antimicrobial Agents and Chemotherapy.

[6]  I. Wang,et al.  Microbial Keratitis in Taiwan: A 20-Year update. , 2019, American journal of ophthalmology.

[7]  H. Yamaguchi,et al.  Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal Keratitis , 2018, Cornea.

[8]  Alexey M. Kozlov,et al.  RAxML-NG: a fast, scalable and user-friendly tool for maximum likelihood phylogenetic inference , 2018, bioRxiv.

[9]  P. Crous,et al.  Removing chaos from confusion: assigning names to common human and animal pathogens in Neocosmospora , 2018, Persoonia.

[10]  G. Walther,et al.  Fusarium Keratitis in Germany , 2017, Journal of Clinical Microbiology.

[11]  O. Gascuel,et al.  SMS: Smart Model Selection in PhyML , 2017, Molecular biology and evolution.

[12]  Toshihisa Takagi,et al.  DNA Data Bank of Japan , 2016, Nucleic Acids Res..

[13]  O. Schein.  Evidence-Based Treatment of Fungal Keratitis. , 2016, JAMA ophthalmology.

[14]  H. Badali,et al.  Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains , 2016, Antimicrobial Agents and Chemotherapy.

[15]  H. Khamis,et al.  Microbiological Investigations of ReNu Plastic Bottles and the 2004 to 2006 ReNu With MoistureLoc-Related Worldwide Fusarium Keratitis Event , 2016, Eye & contact lens.

[16]  Pedro W. Crous,et al.  DNA sequence-based identification of Fusarium: Current status and future directions , 2015, Phytoparasitica.

[17]  Savitri Sharma,et al.  Fusarium keratitis at a tertiary eye care centre in India , 2015, International ophtalmology.

[18]  A. Tavakkol,et al.  Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis , 2014, Mycoses.

[19]  C. Vágvölgyi,et al.  Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex , 2013, Mycoses.

[20]  M. Yu,et al.  Fusarium keratitis in Brazil: genotyping, in vitro susceptibilities, and clinical outcomes , 2013, Clinical ophthalmology.

[21]  W. Shi,et al.  Fusarium Keratitis: Genotyping, In Vitro Susceptibility and Clinical Outcomes , 2013, Cornea.

[22]  Y. Sugita‐Konishi,et al.  Utility of the phylotoxigenic relationships among trichothecene-producing Fusarium species for predicting their mycotoxin-producing potential , 2013, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[23]  K. Katoh,et al.  MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.

[24]  M. Srinivasan,et al.  Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial , 2012, British Journal of Ophthalmology.

[25]  Maxim Teslenko,et al.  MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice Across a Large Model Space , 2012, Systematic biology.

[26]  M. Mannis,et al.  Practice Patterns in the Management of Fungal Corneal Ulcers , 2009, Cornea.

[27]  S. Chuang,et al.  A multi-country outbreak of fungal keratitis associated with a brand of contact lens solution: the Hong Kong experience. , 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[28]  M. Fini,et al.  Utility of molecular sequence analysis of the ITS rRNA region for identification of Fusarium spp. from ocular sources. , 2009, Investigative ophthalmology & visual science.

[29]  E. Rocha,et al.  Epidemiologic Aspects and Clinical Outcome of Fungal Keratitis in Southeastern Brazil , 2009, European journal of ophthalmology.

[30]  D. Geiser,et al.  Taxonomy and phylogeny of the Fusarium dimerum species group , 2009, Mycologia.

[31]  J. Zhao,et al.  Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. , 2008, American journal of ophthalmology.

[32]  Kerry O'Donnell,et al.  Molecular Phylogenetic Diversity, Multilocus Haplotype Nomenclature, and In Vitro Antifungal Resistance within the Fusarium solani Species Complex , 2008, Journal of Clinical Microbiology.

[33]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard , 2008 .

[34]  Gerard Talavera,et al.  Improvement of phylogenies after removing divergent and ambiguously aligned blocks from protein sequence alignments. , 2007, Systematic biology.

[35]  M. Srinivasan,et al.  Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. , 2007, Archives of ophthalmology.

[36]  T. Wong,et al.  An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. , 2006, JAMA.

[37]  Michael Bach,et al.  Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test. , 2006, Investigative ophthalmology & visual science.

[38]  L. Kredics,et al.  Involvement of Fusarium spp. in fungal keratitis. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[39]  M. Mabon,et al.  Fungal Keratitis , 1998, International ophthalmology clinics.

[40]  T. White.  Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics , 1990 .